INVE.A

289

+0.38%↑

INVE.B

288.9

+0.43%↑

HEXA.B

109.15

+0.23%↑

MYCR

216.8

+0.58%↑

HMS

411

-0.92%↓

INVE.A

289

+0.38%↑

INVE.B

288.9

+0.43%↑

HEXA.B

109.15

+0.23%↑

MYCR

216.8

+0.58%↑

HMS

411

-0.92%↓

INVE.A

289

+0.38%↑

INVE.B

288.9

+0.43%↑

HEXA.B

109.15

+0.23%↑

MYCR

216.8

+0.58%↑

HMS

411

-0.92%↓

INVE.A

289

+0.38%↑

INVE.B

288.9

+0.43%↑

HEXA.B

109.15

+0.23%↑

MYCR

216.8

+0.58%↑

HMS

411

-0.92%↓

INVE.A

289

+0.38%↑

INVE.B

288.9

+0.43%↑

HEXA.B

109.15

+0.23%↑

MYCR

216.8

+0.58%↑

HMS

411

-0.92%↓

Search

AddLife AB

Suletud

164.4 -0.9

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

164.4

Max

164.6

Põhinäitajad

By Trading Economics

Sissetulek

199M

318M

Müük

-124M

2.6B

P/E

Sektori keskmine

61.558

68.029

Aktsiakasum

0.83

Dividenditootlus

0.44

Kasumimarginaal

12.335

Töötajad

2,322

EBITDA

6M

235M

Dividendid

By Dow Jones

Dividenditootlus

Sektori keskmine

0.44%

3.56%

Turustatistika

By TradingEconomics

Turukapital

-1.9B

21B

Eelmine avamishind

165.3

Eelmine sulgemishind

164.4

AddLife AB Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

8. aug 2025, 21:43 UTC

Tulu

Constellation Software 2Q Revenue Rises, Profit Shrinks

10. aug 2025, 23:54 UTC

Market Talk

Gold Edges Lower Amid Mixed Signals on Possible U.S. Tariffs -- Market Talk

10. aug 2025, 23:51 UTC

Market Talk

China's July Data Could Confirm Weakening Momentum -- Market Talk

10. aug 2025, 23:38 UTC

Market Talk

Oil Falls Amid Easing Supply-Disruption Concerns -- Market Talk

10. aug 2025, 23:29 UTC

Market Talk

RBA Board Meeting Still Has Some Uncertainty -- Market Talk

10. aug 2025, 23:14 UTC

Market Talk

RBA's Communication With Markets in Spotlight -- Market Talk

10. aug 2025, 22:59 UTC

Omandamised, ülevõtmised, äriostud

Santos: XRG Consortium Confirms Hasn't Discovered Anything That Would Cause Withdrawal of Indicative Proposal

10. aug 2025, 22:59 UTC

Omandamised, ülevõtmised, äriostud

Santos: Decision to Allow XRG Consortium to Finalize Due Diligence, Progress Scheme Implementation Agreement

10. aug 2025, 22:58 UTC

Omandamised, ülevõtmised, äriostud

Santos Extends Exclusivity Period for XRG Consortium to August 22

10. aug 2025, 22:57 UTC

Omandamised, ülevõtmised, äriostud

Santos Extends Exclusivity Period for XRG Consortium

10. aug 2025, 22:55 UTC

Market Talk

Australian Inflation Expectations Continue to Fall -- Market Talk

10. aug 2025, 20:31 UTC

Omandamised, ülevõtmised, äriostud

Spark NZ Says Process to Seek Capital Partner for Data Center Business Ongoing

9. aug 2025, 08:20 UTC

Market Talk

Health Care Roundup: Market Talk

9. aug 2025, 08:20 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

8. aug 2025, 22:42 UTC

Omandamised, ülevõtmised, äriostud

The Paramount Merger Was a Bad Deal for Old Shareholders. Buying the Stock Is a Good Bet for New Ones. -- Barrons.com

8. aug 2025, 21:31 UTC

Market Talk
Tulu

Cautious Long-Term Outlook For Natural Diamond Prices -- Market Talk

8. aug 2025, 21:00 UTC

Tulu

Constellation Software 2Q Rev $2.84B >CSU.T

8. aug 2025, 21:00 UTC

Tulu

Constellation Software 2Q Net $56M >CSU.T

8. aug 2025, 21:00 UTC

Tulu

Constellation Software 2Q EPS $2.66 >CSU.T

8. aug 2025, 20:55 UTC

Market Talk

Ahead of Cisco's Earnings, Investors Should Expect Conservatism -- Market Talk

8. aug 2025, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

8. aug 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

8. aug 2025, 20:35 UTC

Market Talk

Mexico's Industrial Production Seen Higher in June -- Market Talk

8. aug 2025, 20:28 UTC

Tulu

MP Materials Stock Soars Even Higher on Earnings. The Future Looks Bright, Too. -- Barrons.com

8. aug 2025, 20:28 UTC

Tulu

These Stocks Moved the Most Today: Trade Desk, Expedia, SoundHound, Pinterest, Gilead, Peloton, and More -- Barrons.com

8. aug 2025, 20:20 UTC

Omandamised, ülevõtmised, äriostud

Boeing's Spirit AeroSystems Deal Gets U.K. Approval. It's Part of the Turnaround. -- Barrons.com

8. aug 2025, 20:08 UTC

Tulu

Tredegar: Recent Decline in Orders, Which Is a Measure of Future Sales Volume, Is Due to Lower Demand for Aluminum Extrusions in U.S. and Customers Pausing Orders to Evaluate New Higher Tariff >TG

8. aug 2025, 19:34 UTC

Market Talk

Underwhelming Weight Loss Pill Results Might Not Put Off Consumers -- Market Talk

8. aug 2025, 19:15 UTC

Market Talk

U.S. Natural Gas Futures Settle Under $3 -- Market Talk

8. aug 2025, 19:13 UTC

Market Talk

Oil Futures End Volatile Week Lower -- Market Talk

Võrdlus sarnastega

Hinnamuutus

AddLife AB Prognoos

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest AddLife AB

AddLife AB (publ), together with its subsidiaries, provides equipment, consumables, and reagents primarily to healthcare sector, research, colleges, and universities, as well as the food and pharmaceutical industries. The company operates through Labtech and Medtech segments. The Labtech segment offers products, solutions, and services in the areas of diagnostics, and biomedical research and laboratory equipment for plastic consumables, cell biology, reagents, lab, and other instruments. The Medtech segment provides medical device products for surgery, thoracic medicine, neurology, wound care, anaesthesia, intensive care, ear, nose and throat, ostomies, and home healthcare, as well as assistive technology for senior citizens and disabled children. It operates in Sweden, the United Kingdom, Ireland, Spain, Denmark, Norway, Italy, Finland, Switzerland, Germany, rest of Europe, and internationally. AddLife AB (publ) was founded in 1906 and is based in Stockholm, Sweden.